Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Nektar Therapeutics
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nektar Therapeutics
Other Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Other Liabilities
$206.3m
CAGR 3-Years
-15%
CAGR 5-Years
3%
CAGR 10-Years
-1%
Johnson & Johnson
NYSE:JNJ
Other Liabilities
$22.1B
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
4%
Bristol-Myers Squibb Co
NYSE:BMY
Other Liabilities
$4.7B
CAGR 3-Years
-14%
CAGR 5-Years
0%
CAGR 10-Years
5%
Pfizer Inc
NYSE:PFE
Other Liabilities
$24.7B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
Other Liabilities
$7.5B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Other Liabilities
$7.6B
CAGR 3-Years
-7%
CAGR 5-Years
0%
CAGR 10-Years
6%

See Also

What is Nektar Therapeutics's Other Liabilities?
Other Liabilities
206.3m USD

Based on the financial report for Jun 30, 2024, Nektar Therapeutics's Other Liabilities amounts to 206.3m USD.

What is Nektar Therapeutics's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
-1%

Over the last year, the Other Liabilities growth was -16%. The average annual Other Liabilities growth rates for Nektar Therapeutics have been -15% over the past three years , 3% over the past five years , and -1% over the past ten years .

Back to Top